You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
開能健康(300272.SZ):原能集團的下屬子公司原天生物與醫學科研機構尚處於合作研發階段,還未形成營業收入
格隆匯 05-09 20:53

格隆匯5月9日丨開能健康(300272.SZ)公佈關於股票交易異常波動的公吿,公司股票交易價格連續三個交易日(2024年5月7日至2024年5月9日)收盤價格升幅偏離值累計超過30%。根據《深圳證券交易所交易規則》的相關規定,屬於股票交易異常波動的情況。

公司董事會確認,截止公吿披露日,公司不存在《深圳證券交易所創業板股票上市規則》等有關規定應予以披露而未披露的事項或與該事項有關的籌劃、商談、意向、協議等;董事會也未獲悉公司有根據《深圳證券交易所創業板股票上市規則》等有關規定應予以披露而未披露的、對公司股票交易價格產生較大影響的信息;公司前期披露的信息不存在需要更正、補充之處。

特別風險提示:1、公司主營業務為全屋淨水機、全屋軟水機、商用淨化飲水機、RO膜反滲透淨水機、多路控制閥、複合材料壓力容器、膜元件等人居水處理產品及核心部件的研發、製造、銷售與服務,公司經營情況正常,主營業務未發生變化。2、原能集團為公司參股企業,未納入合併報表範圍。3、截止目前,在幹細胞治療領域,原能集團的下屬子公司原天生物與醫學科研機構尚處於合作研發階段,還未形成營業收入,預計2024年度也不會形成營業收入,對公司的經營業績不構成影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account